FDA Inspection 1207182 — Huntington Reproductive Center Medical Group

Huntington Reproductive Center Medical Group — FEI 3006501046

The FDA completed an inspection of Huntington Reproductive Center Medical Group on June 1, 2023 in Los Angeles, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 1, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Los Angeles, CA (United States)